Search filters

List of works by Natasha Woodward

A first-in-human, phase 1, dose-escalation study of ABBV-176, an antibody-drug conjugate targeting the prolactin receptor, in patients with advanced solid tumors

scientific article published on 10 June 2020

Absent progesterone receptor expression in the lymph node metastases of ER-positive, HER2-negative breast cancer is associated with relapse on tamoxifen.

scientific article published on 17 April 2017

Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies

scientific article published on 24 March 2016

Emerging data and future directions for CDK4/6 inhibitor treatment of patients with hormone receptor positive HER2-non-amplified metastatic breast cancer

scientific article published on 01 October 2018

Exercise therapies for preventing or treating aromatase inhibitor-induced musculoskeletal symptoms in early breast cancer

scientific article published on 29 January 2020

Hormone receptor positive, HER2 negative metastatic breast cancer: A systematic review of the current treatment landscape

scientific article published on March 2016

Hormone receptor positive, HER2 negative metastatic breast cancer: Future treatment landscape.

scientific article published on March 2016

Hormone receptor positive, HER2 negative metastatic breast cancer: Impact of CDK4/6 inhibitors on the current treatment paradigm

scientific article published on 01 October 2018

Improved relapse-free survival on aromatase inhibitors in breast cancer is associated with interaction between oestrogen receptor-α and progesterone receptor-b

scientific article published on 09 November 2018

Maintaining Dose Intensity of Adjuvant Chemotherapy in Older Patients With Breast Cancer

scientific article published on 28 April 2018

Management of aromatase inhibitor induced musculoskeletal symptoms in postmenopausal early Breast cancer: A systematic review and meta-analysis.

scientific article published on 22 January 2017

Management of patients treated with pertuzumab in the Australian clinical practice setting

scientific article published on June 2016

Outcomes in Clinically Relevant Patient Subgroups From the EMBRACA Study: Talazoparib vs Physician's Choice Standard-of-Care Chemotherapy

scientific article published on 21 October 2019

Results From the First Multicenter, Open-label, Phase IIIb Study Investigating the Combination of Pertuzumab With Subcutaneous Trastuzumab and a Taxane in Patients With HER2-positive Metastatic Breast Cancer (SAPPHIRE)

scientific article published on 27 February 2019

Toxic optic neuropathy in the setting of docetaxel chemotherapy: a case report

scientific article

Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.

scientific article published in August 2009